Peptides as regulators of the immune system: Emphasis on somatostatin

Peptides

Volumn 21, Issue 12, 2000, Pages 1941-1964

  Krantic, Slavica ^a  

^a INSERM   (France)

Author keywords

Cytokine and immunoglobulin secretion; Lymphocytes; Macrophages; Neuro immune modulation; Neuropeptides; NK cells; Proliferation; Somatostatin

Indexed keywords

ARGIPRESSIN; HYPOTHALAMUS RELEASING FACTOR; NEUROPEPTIDE; NEUROPEPTIDE Y; PEPTIDE; PROTIRELIN; SOMATOSTATIN; TRIPTORELIN; VASOACTIVE INTESTINAL POLYPEPTIDE; CALCITONIN GENE RELATED PEPTIDE; CD4 ANTIGEN; COLONY STIMULATING FACTOR 1; CORTICOTROPIN RELEASING FACTOR; CYCLIC AMP; CYTOKINE; ERYTHROPOIETIN RECEPTOR; GAMMA INTERFERON; GROWTH HORMONE RELEASING FACTOR; INTERLEUKIN 1; SOMATOSTATIN 14; SOMATOSTATIN RECEPTOR; SUBSTANCE P; TUMOR NECROSIS FACTOR ALPHA;

CELL PROLIFERATION; CYTOKINE RELEASE; IMMUNE SYSTEM; IMMUNOCOMPETENT CELL; IMMUNOGLOBULIN PRODUCTION; IMMUNOMODULATION; LYMPHOCYTE; MACROPHAGE; NATURAL KILLER CELL; NERVOUS SYSTEM; PRIORITY JOURNAL; REVIEW; B LYMPHOCYTE; BINDING SITE; CELL INTERACTION; CELL TYPE; HUMAN; IMMUNE RESPONSE; IMMUNOREGULATION; MULTIPLE SCLEROSIS; NEUROMODULATION; NEUROTRANSMISSION; NONHUMAN; PROTEIN EXPRESSION; RECEPTOR BINDING; SIGNAL TRANSDUCTION; T LYMPHOCYTE;

ANIMALS; B-LYMPHOCYTES; BINDING SITES; BRAIN; CELL DIVISION; CYTOKINES; HUMANS; IMMUNE SYSTEM; LEUKEMIA; LIGANDS; MODELS, BIOLOGICAL; MULTIPLE SCLEROSIS; NERVOUS SYSTEM; NEUROPEPTIDES; RATS; RECEPTORS, SOMATOSTATIN; SOMATOSTATIN; T-LYMPHOCYTES;

EID: 0034530398     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0196-9781(00)00347-8     Document Type: Review

References (165)

1. Immunomodulatory activities of the somatostatin analogue BIM 23014c: Effect on murine lymphocyte proliferation and natural killer activity
2. Evidence that somatostatin is localized and synthesized in lymphoid organs
3. Somatostatin antisense oligodeoxynucleotide-mediated stimulation of lymphocyte proliferation in culture
4. Somatostatin controls Kaposi's sarcoma tumor growth through inhibition of angiogenesis
5. The IL-1 system: Receptors, ligands, and ICE in the brain and their involvement in the fiver responses
6. Immunomodulatory activities of the somatostatin receptor subtype analogues on human peripheral blood lymphocytes
7. Immunoactivation enhances the concentration of luteinizing hormone-releasing hormone peptide and its gene expression in human peripheral T lymphocytes
8. Jurkat cell proliferative activity is increased by luteinizing hormone-releasing hormone
9. Receptors for IL-1 (alpha and beta) in mouse brain: Mapping and neuronal localization in hippocampus
10. Regional and cellular codistribution of IL-1beta messenger RNA in the adult rat brain: Possible relationship to the regulation of nerve growth factor synthesis
11. Identification and characterization of [125]arginine-vasopressin binding sites on human peripheral blood mononuclear cells
12. Innervation of lymphoid organs and neurotransmitter-lymphocyte interactions
13. Immune-neuro-endocrine interactions: Facts and hypothesis
14. Identification of human mononuclear leukocytes bearing receptors for somatostatin and glucagon
15. The syntax of immune-neuroendocrine communication
16. Granuloma T lymphocytes in murine schistosomiasis mansoni have somatostatin receptors and respond to somatostatin with decreased IFNg secretion
17. Modulation of the mRNAs encoding substance P and its receptor in rat macrophages by LPS
18. IL-1 immunoreactive innervation of the human hypothalamus
19. Selective regulation of T cell development and function by calcitonin-related peptide in thymus and spleen. An example of differential regional regulation of immunity by the neuroendocrine system
20. Substance P enhances IL-2 expression in activated human T cells
21. Functional and molecular characterization of VIP receptors and signal transduction in human and rodent systems
22. Somatostatin increases mitogen-induced IL-2 secretion and proliferation of human Jurkat T-cells via sst3 receptor isotype
23. Corticotropin-releasing hormone augments natural killer cell activity through a naloxone-sensitive pathway
24. Cytokines in the central nervous system: Expression of macrophage colony stimulating factor and its receptors during development
25. Somatostatin and macrophage function: Modulation of hydrogen peroxide, nitric oxide and TNF release
26. Expression cloning of a human corticotropin-releasing-factor receptor
27. Cervical lymphatics, the blood-brain barrier and the immunoreactivity of the brain
28. Interferon inhibits synaptic potentiation in rat hippocampus
29. Specific binding sites for vasoactive intestinal peptide on nonadherent peripheral blood lymphocytes
30. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide prevent inducible nitric oxid synthase transcription in macrophages by inhibiting NF-κ B and IFN regulatory factor 1 activation
31. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit IL-12 transcription by regulating nuclear factor kB and Ets activation
32. Differential VIP and VIP1 receptor gene expression in rat thymocyte subsets
33. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide enhance IL-10 production by murine macrophages: In vitro and in vivo studies
34. Characterization of gene expression of VIP and VIP1-receptor in rat peritoneal lymphocytes and macrophages
35. Vasoactive intestinal peptide and pituitary adenylate cyclase-activatin polypeptide inhibit endotoxin-induced TNF-α production by macrophages: In vitro and in vivo studies
36. VIP and PACAP differentially regulate the costimulatory activity of resting and activated macrophages through the modulation of B7.1 and B7.2 expression
37. Effects of TGF-β on the immune system: Implication for cancer immunotherapy
38. Interleukin 1: The first interleukin
39. sst5 somatostatin receptor mRNA induction by mitogenic activation of human T-lymphocytes
40. Neurohypophyseal hormone receptors in the rat thymus, spleen and lymphocytes
41. Presynaptic inhibitory effect of TNF-α on the release of noradrenaline in isolated median eminence
42. SSTR2A is the dominant somatostatin receptor subtype expressed by inflammatory cells, is widely expressed and directly regulates T cell IFN-γ release
43. T lymphocytes isolated from the hepatic granulomas of schistosome-infected mice express somatostatin receptor subtype II (SSTR2) messenger RNA
44. Rat spleen lymphocytes contain an immunoreactive and bioactive luteinizing hormone-releasing hormone
45. The neurobiology of somatostatin
46. Somatostatin receptors on pituitary somatotrophs, thyrotrophs and lactotrophs: Pharmacological evidence for loose coupling to adenylate cyclase
47. Effects of somatostatin on human intestinal lamina propria lymphocytes. Modulation of lymphocyte activation
48. Visualization and characterization of IL-1 receptors in brain
49. In situ hybridization histochemistry localization of IL-3 mRNA in mouse brain
50. Noradrenergic and peptidergic inervation of lymphoid tissue
51. Inhibition of LPS-induced TNF-α production by calcitonin gene-related peptide (CGRP) in cultured mouse peritoneal macrophages
52. In vitro characterization of somatostatin receptors in human thymus and effects of somatostatin and octreotide on cultured thymic epithelial cells
53. Somatostatin and its analog lanreotide inhibit the proliferation of dispersed human non-functioning pituitary adenoma cells in vitro
54. Calcitonin gene-related peptide inhibits proliferation and antigen presentation by human peripheral blood mononuclear cells: Effects on B7, IL-10 and IL-12
55. Cultured sympathetic neurons synthesize and release the cytokine interleukin 1
56. Somatostatin-dependent adenylyl cyclase activity in non-activated and mitogen-activated human T cells: Evidence for uncoupling of sst3 receptor from adenylyl cyclase
57. Endogenous somatostatin-like peptides of rat basophilic leukemia cells
58. Inhibition by somatostatin of the release of mediators from human basophils and rat leukemia basophils
59. The effects of LHRH and TRH on human interferon-γ production in vivo and in vitro
60. Growth hormone releasing hormone receptors on thymocytes and splenocytes from rats
61. Thyrotropin releasing hormone (TRH) induces gamma interferon release
62. Effect of thyrotropin-releasing hormone on immune functions of peripheral blood mononuclear cells
63. Somatostatin reduces the release of colony-stimulating activity (CSA) from PHA-activated mouse spleen lymphocytes
64. Somatostatin receptors on human lymphocytes and leukemia cells
65. Substance P augments IL-10 and TNF-α release by human blood monocytes and macrophages
66. IL-1 beta modulates the acute release of growth-hormone-releasing hormone and somatostatin from rat hypothalamus in vitro, whereas TNF and IL-6 have no effect
67. Detailed in vivo analysis of interferon-γ induced major histocompatibility complex expression in the central nervous system: Astrocytes fail to express major histocompatibility complex class I and II molecules
68. Enhancement of phagocytosis by calcitonin gene-related peptide (CGRP) in cultured mouse peritoneal macrophages
69. Cytokines and endocrine function: An interaction between the immune and neuroendocrine systems
70. Growth inhibitory effects of somatostatin on human leukemia cell lines mediated by somatostatin receptor subtype 1
71. A nucleotide regulatory site for somatostatin inhibition of adenylate cyclase in S49 lymphoma cells
72. The effects of somatostatin and SMS 201-995 on experimentally induced pancreatitis and endotoxaemia in rats and on monocyte activity in patients with cirrhosis and portal hypertension
73. Thymic vasopressin (AVP) transgene expression in rats: A model for study of thymic AVP hyperexpression in T cell differentiation
74. Effect of neuropeptides betta-MSH, neurotensin, NPY, PHI, somatostatin and substance P on proliferation of lymphocytes in vitro
75. A novel arginine vasopressin-binding peptide that blocks arginine vasopressin modulation of immune function
76. Transforming growth factor beta's 1, 2 and 3 inhibit proliferation of ramified microglia on an astrocyte monolayer
77. Interleukin 3 as a tropic factor for central cholinergic neurons in vitro and in vivo
78. The adenylate cyclase-cAMP-protein kinase A pathway and regulation of the immune response
79. Somatostatin may participate in the antiinflammatory actions of glucocorticoids
80. The role of IL-1 in the corticotropin-releasing factor and arginine-vasopressin-induced secretion of immunoreactive β-endorphin by human peripheral mononuclear cells
81. Induction of β-endorphin secretion by lymphocytes after subcutaneous (s.c.) administration of corticotropin-releasing factor
82. Differential effects of neuropeptides on cytokine production by mouse helper cell subsets
83. Effect of vasoactive intestinal peptide, somatostatin and substance P on spontaneous IgE and IgG4 production in atopic patients
84. Identification and characterization of receptors for TNF alpha in the brain
85. Somatostatin (SRIF) stimulates the release of IL-6 (IL-6) from human peripheral blood monocytes (PBM) in vitro
86. Measles virus modulates human T-cell somatostatin receptors and their coupling to adenylyl cyclase
87. Gastrointestinal regulatory peptides modulate in vitro immune reactions of mouse lymphoid cells
88. Immuno-autoradiographic localization of IL-2-like immunoreactivity and IL-2 receptors (Tac antigen-like immunoreactivity) in the rat brain
89. Subdiaphragmatic vagotomy blocks induction of IL-1beta mRNA in mice brain in response to peripheral LPS
90. Expression of vasoactive intestinal peptide in lymphocytes: A possible endogenous role in the regulation of the immune system
91. Neuropeptides, by direct interaction with T cells, induce cytokine secretion and break the commitment to a distinct T helper phenotype
92. Neuropeptides, via specific receptors, regulate T-cell adhesion to fibronectin
93. Cloning and characterization of the human corticotropin-releasing factor-2 receptor complementary deoxyribonucleic acid
94. Localization of IL-1 receptor antagonist mRNA in rat brain
95. Interferon-γ-like immunoreactivity in certain neurons of central and peripheral nervous system
96. Thymocytes express mRNA that is identical to hypothalamic luteinizing hormone-releasing hormone mRNA
97. Luteinizing hormone-releasing hormone-binding sites in the rat thymus: Characteristics and biological function
98. Functional expression of receptors for calcitonin gene-related peptide, calcitonin, and vasoactive intestinal peptide in the human thymus and thymomas from myasthenia gravis patients
99. Regulation of VIP production and secretion by murine lymphocytes
100. VIP and PACAP enhance IL-6 release and mRNA levels in resting peritoneal macrophages
101. Somatostatin has an antiproliferative effect on concavalin-activated rat thymocytes
102. Changes with age in the modulation of natural killer activity of murine leukocytes
103. Expression analysis of the thyrotropin-releasing hormone receptor (THRH) in the immune system using agonist anti-THRH monoclonal antibodies
104. Cytokines in inflammatory brain lesions: Helpful and harmful
105. Effects of kainic acid on messenger RNA levels of IL-1 beta, IL-6, TNF alpha and LIF in the rat brain
106. Substance P induces TNF in an ex vivo model system
107. Identification of lymphoid cell lines bearing receptors for somatostatin
108. Modulation of T lymphocyte function by neuropeptides
109. Influence of β-endorphin, somatostatin, substance P and vasoactive intestinal peptide on the proliferative response of human peripheral blood T lymphocytes to mercuric chloride
110. Modulating effect of β-endorphin, somatostatin, substance P and vasoactive intestinal peptide on the proliferative response of peripheral blood T lymphocytes of nickel-allergic patients to nickel sulfate
111. Vasoactive intestinal peptide stimulation of adenylate cyclase in purified human leukocytes
112. Class II transactivator and class II MHC gene expression in microglia: Modulation by cytokines TGF-β, Il-4, IL-13 and IL-10
113. Impairment of hypothalamic-pituitary-thyroid function in rats treated with human recombinant TNF alpha (cachectin)
114. Somatostatin and its receptor family
115. Effect of somatostatin on the proliferation of mouse spleen lymphocytes in vitro
116. Inhibition by somatostatin of the proliferation of T-lymphocytes and Molt-4 lymphoblasts
117. Modulation of cytokine production in activated human monocytes by somatostatin
118. Molecular cloning of NPY-Y1 receptor cDNA from rat splenic lymphocytes: Evidence of low levels of mRNA expression and 125I-NPY binding sites
119. TRH receptor on immune cells: In vitro and in vivo stimulation of human lymphocyte and rat splenocyte DNA synthesis by TRH
120. Central action of IL-1 in altering the release of TSH, growth hormone and prolactin in the male rat
121. Preferential location of somatostatin receptors in germinal centers of human gut lymphoid tissue
122. Immunohistochemical detection of somatostatin sst2A receptors in the lymphatic, smooth muscular and peripheral nervous systems of the human gastrointestinal tract: Facts and artifacts
123. The chronic intracerebroventricular infusion of interleukin 1-β alters the activity of the hypothalamic-pituitary-gonadal axis of cycling rats. I. Effects on LHRH and gonadotropin biosynthesis and secretion
124. Selective facilitation of putative corticotropin-releasing factor-secreting neurons by IL-1
125. IL-1 stimulates the secretion of hypothalamic corticotropin-releasing factor
126. Localization of IL-6 receptor (IL-6R) mRNAs in rat hypothalamus
127. Cloning and expression of murine IL-12
128. Neuropeptide Y is an inducible gene in the human immune system
129. Distribution of somatostatin receptors on murine spleen and Peyer's patch T and B lymphocytes
130. The murine IgA-secreting plasmacytoma MOPC-315 expresses somatostatin receptors
131. Proliferation of astrocytes in vitro in response to cytokines: A primary role for TNF
132. IL-1 beta augments release of norepinephrine, dopamine and serotonin in the rat anterior hypothalamus
133. cDNA expression cloning of the IL-1 receptor, a member of the immunoglobulin superfamily
134. Inhibitory effects of somatostatin-14 and some analogs on human natural killer activity
135. Modulation of human natural killer activity by vasoactive intestinal peptide (VIP) family. VIP, glucagon and GHRF specifically inhibit NK activity
136. Neuropeptide regulation of human thymocyte, guinea pig T lymphocyte and rat B lymphocyte mitogenesis
137. Distinct subsets of somatostatin receptors on cultured human lymphocytes
138. Differential effects of vasoactive intestinal peptide, substance P and somatostatin on immunoglobulin synthesis and proliferations by lymphocytes from Peyer's patches, mesenteric lymph nodes and spleen
139. In vitro studies of immunoregulation by Substance P and Somatostatin
140. Corticotrophin-releasing factor-like immunoreactivity and mRNA in human leukocytes
141. Production of growth hormone-releasing hormone-like peptide and its mRNA by human lymphocytes
142. Vasoactive intestinal peptide inhibits interleukin (IL)-2 and IL-4 production through different molecular mechanisms in T cells activated via the T cell receptor/CD3 complex
143. Analysis of cytokine receptor messenger RNA expression in human glioblastoma cells and normal astrocytes by reverse-transcription PCR
144. IL-1 receptors in mouse brain: Characterization and neuronal localization
145. Calcitonin gene-related peptide potentiates LPS-induced IL-6 release from mouse peritoneal macrophages
146. Localization of TNF alpha and IL-1 alpha immunoreactivities in striatal neurons after surgical injury in the hippocampus
147. Immunohistochemical localization of somatostatin receptor sst2A in human rheumatoid synovium
148. Somatostatin receptor subtype expression in cells of the rat immune system during adjuvant arthritis
149. Hypothalamic IL-1 in physiology and pathology
150. Expression of somatostatin receptor subtype 2 mRNA in human lymphoid cells
151. Neuropeptides and their receptors in the immune system
152. Interferon-γ inhibits stimulated adrenocorticotropin, prolactin and growth hormone secretion in normal anterior pituitary cell cultures
153. Evidence of type I and II transforming growth factor-β receptors in central nervous tissues: Changes induced by focal cerebral ischemia
154. Identification and characterization of immunoreactive calcitonin gene-related peptide from lymphocytes of the rat
155. Functional corticotropin releasing factor (CRH) receptors in mouse spleen: Evidence for adenylate cyclase coupling
156. Corticotropin releasing-factor receptors in mouse spleen: Identification, autoradiographic localization and regulation by divalent cations and guanine nucleotides
157. Macrophages within the granulomas of murine schistosomiasis mansoni are a source of a somatostatin 1-14 like molecule
158. The substance P and somatostatin interferon-γ immunoregulatory circuit
159. Corticotropin-releasing activity of monokines
160. Vasoactive intestinal peptide inhibits interleukin (IL)-2 and IL-4 production in murine thymocytes activated via the TCR/CD3 complex
161. Natural killer cell activity in vasopresin-defficient rats (Brattleboro strain)
162. Cytokin-specific central monoamine alterations induced by IL-1, 2 and 6
163. Effects of growth hormone releasing hormone on human peripheral blood leukocyte chemotaxis and migration in normal subjects